Yourway Transport Biopharma Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 54.35%
- Profit Growth 162.75%
- Ebitda 165.26%
- Net Worth 1139.81%
- Total Assets 100.89%
About Yourway Transport Biopharma Services
Yourway Transport Biopharma Services Private Limited (YTBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 2012 and has a history of 12 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gulamali Jaffer and Ballabha Barik serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U63030MH2012PTC232876
- Company No.
232876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Yourway Transport Biopharma Services?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulamali Jaffer  | Director | 28-Jan-2013 | Current |
Ballabha Barik  | Additional Director | 02-Jan-2018 | Current |
Financial Performance of Yourway Transport Biopharma Services.
Yourway Transport Biopharma Services Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.35% increase. The company also saw a substantial improvement in profitability, with a 162.75% increase in profit. The company's net worth Soared by an impressive increase of 1139.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yourway Transport Biopharma Services?
In 2022, Yourway Transport Biopharma Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yourway Transport Biopharma Services?
Unlock and access historical data on people associated with Yourway Transport Biopharma Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yourway Transport Biopharma Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yourway Transport Biopharma Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
